These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33342794)

  • 1. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
    Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
    J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.
    Bergom C; Kelly T; Morrow N; Wilson JF; Walker A; Xiang Q; Ahn KW; White J
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):821-8. PubMed ID: 22208973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.
    Gupta A; Khan AJ; Yegya-Raman N; Sayan M; Ahlawat S; Ohri N; Goyal S; Moore DF; Eladoumikdachi F; Toppmeyer D; Haffty BG
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):267-274. PubMed ID: 31175905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.
    Olivotto IA; Whelan TJ; Parpia S; Kim DH; Berrang T; Truong PT; Kong I; Cochrane B; Nichol A; Roy I; Germain I; Akra M; Reed M; Fyles A; Trotter T; Perera F; Beckham W; Levine MN; Julian JA
    J Clin Oncol; 2013 Nov; 31(32):4038-45. PubMed ID: 23835717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
    De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
    Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
    Ghannam AA; Khedr RA
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
    Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
    Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
    Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
    Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer hypofractionated radiotherapy in 2-weeks with 2D technique: 5-year clinical outcomes of a phase 2 trial.
    Yadav BS; Dahiya D; Gupta A; Rana D; Robert N; Sharma M; Rao B
    Rep Pract Oncol Radiother; 2021; 26(4):503-511. PubMed ID: 34434565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Toxicity and Cosmetic Outcomes After Accelerated Partial Breast Irradiation or Whole Breast Irradiation Using 3-Dimensional Conformal External Beam Radiation Therapy.
    Yadav BS; Loganathan S; Sharma SC; Singh R; Dahiya D
    Adv Radiat Oncol; 2020; 5(2):171-179. PubMed ID: 32280816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.